Hypersensitivity reaction to rivaroxaban with a successful switch to apixaban: A case report
Key Clinical Message The precise management of hypersensitivity reactions to direct oral anticoagulants (DOACs) and the potential for cross‐reactivity among different DOACs remain unclear. In such cases, switching between DOACs may be feasible and could be considered, but close monitoring for advers...
| Published in: | Clinical Case Reports |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-08-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.9213 |